NCT05253053 2025-06-12To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsTransThera Sciences (Nanjing), Inc.Phase 1/2 Completed84 enrolled
NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 4 FDA
NCT01938612 2021-03-12A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid TumoursAstraZenecaPhase 1 Completed269 enrolled
NCT00423254 2010-08-03Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.Mannkind CorporationPhase 1 Completed12 enrolled